These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17126073)

  • 21. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
    Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L
    J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
    Juurlink DN; Mamdani MM; Lee DS; Kopp A; Austin PC; Laupacis A; Redelmeier DA
    N Engl J Med; 2004 Aug; 351(6):543-51. PubMed ID: 15295047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with beta blockers in heart failure mortality trials.
    Eichhorn EJ
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V21-9. PubMed ID: 10526700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract]   [Full Text] [Related]  

  • 27. Reducing readmissions for congestive heart failure.
    Hoyt RE; Bowling LS
    Am Fam Physician; 2001 Apr; 63(8):1593-8. PubMed ID: 11327436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Cohn JN; Tognoni G;
    N Engl J Med; 2001 Dec; 345(23):1667-75. PubMed ID: 11759645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW; Alexander KP
    J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors.
    Meune C; Wahbi K; Fulla Y; Cohen-Solal A; Duboc D; Mahé I; Simoneau G; Bergmann JF; Weber S; Mouly S
    Eur J Heart Fail; 2007 Feb; 9(2):197-201. PubMed ID: 16914369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natriuretic peptides in heart failure: should therapy be guided by BNP levels?
    O'Donoghue M; Braunwald E
    Nat Rev Cardiol; 2010 Jan; 7(1):13-20. PubMed ID: 19935742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New therapies for heart failure.
    Riggs JM
    RN; 2004 Mar; 67(3):28-32; quiz 33. PubMed ID: 15065491
    [No Abstract]   [Full Text] [Related]  

  • 35. Brain natriuretic peptide-guided management of chronic heart failure: first do no harm.
    Richards AM
    Eur J Heart Fail; 2013 Aug; 15(8):832-4. PubMed ID: 23821462
    [No Abstract]   [Full Text] [Related]  

  • 36. Aldosterone antagonism in heart failure.
    Richards AM; Nicholls MG
    Lancet; 1999 Sep; 354(9181):789-90. PubMed ID: 10485716
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharma-clinics. How I treat...symptomatic heart failure].
    Kulbertus H
    Rev Med Liege; 1999 Jul; 54(7):625-8. PubMed ID: 10495687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone antagonists: the most underutilized class of heart failure medications.
    Guglin M; Awad KE; Polavaram L; Vankayala H
    Am J Cardiovasc Drugs; 2007; 7(1):75-9. PubMed ID: 17355168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neurohumoral systems escape control. Heart failure symptoms even once--long-term high risk prognosis].
    MMW Fortschr Med; 2005 Jul; 147(27-28):45. PubMed ID: 16041943
    [No Abstract]   [Full Text] [Related]  

  • 40. Undertreatment of heart failure has high cost to patients.
    Berry C; McMurray J
    BMJ; 2001 Mar; 322(7288):731-2. PubMed ID: 11264218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.